The 'gold standard' for oncogenic HPV detection is the demonstration of transcriptionally active high-risk HPV in tumor tissue. However, detection of E6/E7 mRNA by quantitative reverse transcription polymerase chain reaction (qRT-PCR) requires RNA extraction which destroys the tumor tissue context critical for morphological correlation and has been difficult to be adopted in routine clinical practice. Our recently developed RNA in situ hybridization technology, RNAscope, permits direct visualization of RNA in formalin-fixed, paraffin-embedded (FFPE) tissue with single molecule sensitivity and single cell resolution, which enables highly sensitive and specific in situ analysis of any RNA biomarker in routine clinical specimens. The RNAscope HPV assay was designed to detect the E6/E7 mRNA of seven high-risk HPV genotypes (HPV16, 18, 31, 33, 35, 52, and 58) using a pool of genotype-specific probes. It has demonstrated excellent sensitivity and specificity against the current 'gold standard' method of detecting E6/E7 mRNA by qRT-PCR. HPV status determined by RNAscope is strongly prognostic of clinical outcome in oropharyngeal cancer patients.
Introduction
High-risk human papillomavirus (HR-HPV) infection accounts for approximately 5% of all cancers worldwide 1 . The incidence of HPV-associated oropharyngeal cancer has increased during the past decades, especially among men. HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) will likely constitute a majority of all head and neck cancers in the United States in the next 20 years 2 . Oropharyngeal squamous cell carcinomas caused by HPV are associated with favorable survival, and tumor HPV status is a strong and independent prognostic factor for survival 3 .
Evidence for transcriptional activation of the viral oncogenes E6 and E7 is regarded as the gold standard for the presence of clinically relevant HPV 4 . However, detection of E6/E7 mRNA from fresh tumor tissue by RT-PCR technique is not practical in routine clinical practice and has been limited to the research laboratories. Recently, we have developed a novel RNA ISH technology called RNAscope, which enables multiplex detection in individual cells with single RNA molecule sensitivity in formalin fixed paraffin embedded tissue specimens (FFPE) [5] [6] [7] [8] [9] [10] . We provided three lines of evidence for single molecule detection 5 . First, the RNAscope probe design and signal amplification system allowed detection of single copy HER2 genomic DNA targets in HeLa and SK-BR-3 cell lines. Second, when compared with HER2 genomic DNA signals, the distribution of the fluorescent intensities of HER2 mRNA signal dots in HeLa cells was consistent with one molecule per dot. Thirdly, the number of HER2 mRNA signal dots per cell matched closely the HER2 mRNA copy number estimated by a solution-based quantification assay, further supporting single molecule detection. Furthermore, counterstaining of nuclei with DAPI in fluorescent microscopy or with hematoxylin in brightfield microscopy allows visualization of individual nuclei, which in turn allows detection and quantification of RNA targets on a single-cell basis 10 . The ability to analyze gene expression in situ in routine clinical specimens makes RNAscope a promising platform for diagnostic pathology, especially those FFPE tissue section-based assays 10, 11 . We have developed an RNAscope-based HPV assay to detect E6/E7 mRNA of seven high-risk HPV genotypes (HPV16, 18, 31, 33, 35, 52, and 58) using a pool of genotype-specific probes. Our recent studies in OPSCC have shown that the RNAscope HPV assay is highly sensitive and specific in determining HPV status on FFPE tissues [12] [13] [14] [15] [16] [17] , and also informs prognosis in OPSCC 12, 16 .
The principle of the RNAscope technology has been previously described 5 
RNAscope Assay Deparaffinization and Dehydration
After baking, deparaffinize tissue sections in xylene for 2 x 5 min with frequent agitation, and dehydrate in 100% EtOH for 2 x 3 min with frequent agitation. Air dry for 5 min and draw a hydrophobic barrier around the tissue section with a Hydrophobic Barrier Pen. 
Discussion
The RNAscope HPV assay allowed direct visualization of E6/E7 mRNA in situ in HPV-associated head and neck squamous cell carcinoma. The RNAscope assay is fully compatible with routinely fixed tumor tissue and preserves tissue morphology for histopathological correlations ( Figure  2) . A key advantage of the RNAscope assay over conventional CISH methods is that it specifically amplifies the hybridization signals ( Figures  2B and 2E ) without amplifying the background noise (Figures 2C and 2F) .
In practice, the RNAscope HPV assay procedure can be completed within 8 hr or conveniently divided over two days. The RNAscope HPV assay has been used to determine HPV status in head and neck squamous cell carcinoma [12] [13] [14] [15] [16] , demonstrating 97% sensitivity and 93% specificity using qRT-PCR as the reference method 16 . Conventional chromogenic ISH for HR-HPV DNA is highly specific but has a sensitivity of ~80% 12 . Immunohistochemical (IHC) staining for the cellular surrogate marker p16 demonstrates excellent sensitivity but may generate false positive results 15, 18 , especially in nonoropharyngeal head and neck cancers 15 . The current "gold standard" method of qRT-PCR for HPV E6/E7 mRNA detection requires fresh frozen tissue for optimal results and is technically complex, which limits its use to the research laboratory only. In addition, it requires RNA extraction which makes it impossible to correlate HR-HPV E6/E7 mRNA expression with histopathology.
There are several critical factors for the success of the RNAscope assay. First, for best results, tissues should be fixed in fresh 10% neutralbuffered formalin at room temperature for 16-32 hr according to ASCO/CAP guidelines 19 . Second, the HybEZ oven is highly recommended since it enables optimal control of temperature and humidity for probe hybridization and signal amplification steps. Thirdly, it is important to remove excess residual buffers before each step but still keep the tissue section from drying during any of these steps. The manual RNAscope procedure described here has been fully automated on a commercial slide auto-staining system 10 . This should greatly facilitate standardization of assay conditions and saving precious manual labor in clinical pathology laboratories. In addition, dedicated image analysis software has been developed
